Advertisement
Twist Bioscience Corporation

Twist Bioscience Corporation (TWST) Stock Overview

Explore Twist Bioscience Corporation’s financial performance, market position, analyst ratings, and future outlook.

TWSTNASDAQ
HealthcareMedical - Diagnostics & Research
$67.77
$2.29(3.27%)
U.S. Market opens in 12h 33m
Advertisement

Twist Bioscience Corporation (TWST)

Meyka AI Score

Z

Key Financials

Market Cap4.2B
P/E Ratio-51.56
EPS (TTM)$-1.32
ROE-0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$42.49
3 Months$26.59
1 Year Target$42.09

TWST Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Twist Bioscience Corporation (TWST) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.65, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $42.09.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -51.56 and a market capitalization of 4.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.27%
5-Day Change
-6.32%
1-Month Change
19.21%
3-Month Change
49.27%
6-Month Change
106.74%
Year-to-Date (YTD) Change
113.65%
1-Year Change
96.72%
3-Year Change
268.72%
5-Year Change
-39.31%
All-Time (Max) Change
384.07%

Contact Information

800 719 0671
681 Gateway Boulevard, South San Francisco, CA, 94080

Company Facts

923 Employees
IPO DateOct 31, 2018
CountryUS
Actively Trading

Frequently Asked Questions